Neveu, Cindy’s team published research in Journal of Medicinal Chemistry in 2012-09-13 | 180181-05-9

Journal of Medicinal Chemistry published new progress about Appetite depressants. 180181-05-9 belongs to class piperidines, and the molecular formula is C22H23NO4, Recommanded Product: 2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)acetic acid.

Neveu, Cindy; Lefranc, Benjamin; Tasseau, Olivier; Do-Rego, Jean-Claude; Bourmaud, Adele; Chan, Philippe; Bauchat, Patrick; Marec, Olivier Le; Chuquet, Julien; Guilhaudis, Laure; Boutin, Jean A.; Segalas-Milazzo, Isabelle; Costentin, Jean; Vaudry, Hubert; Baudy-Floc’h, Michele; Vaudry, David; Leprince, Jerome published the artcile< Rational design of a low molecular weight, stable, potent, and long-lasting GPR103 aza-β3-pseudopeptide agonist>, Recommanded Product: 2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)acetic acid, the main research area is RFamide neuropeptide analog aza pseudopeptide GPR103 agonist synthesis conformation; peptide RFamide neuropeptide aza beta pseudopeptide agonist drug design; calcium mobilizing structure activity appetite depressants hydrogen bond.

26RFa, a novel RFamide neuropeptide, is the endogenous ligand of the former orphan receptor GPR103. Intracerebroventricular injection of 26RFa and its C-terminal heptapeptide, 26RFa(20-26), stimulates food intake in rodents. To develop potent, stable ligands of GPR103 with low mol. weight, we have designed a series of aza-β3-containing 26RFa(20-26) analogs for their propensity to establish intramol. hydrogen bonds, and we have evaluated their ability to increase [Ca2+]i in GPR103-transfected cells. We have identified a compound, [Cmpi21,aza-β3-Hht23]26RFa(21-26), which was 8-fold more potent than 26RFa(20-26) in mobilizing [Ca2+]i. This pseudopeptide was more stable in serum than 26RFa(20-26) and exerted a longer lasting orexigenic effect in mice. This study constitutes an important step toward the development of 26RFa analogs that could prove useful for the treatment of feeding disorders.

Journal of Medicinal Chemistry published new progress about Appetite depressants. 180181-05-9 belongs to class piperidines, and the molecular formula is C22H23NO4, Recommanded Product: 2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)acetic acid.

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

 

Mothukuri, Ganesh K’s team published research in Chemical Science in 2020 | 180181-05-9

Chemical Science published new progress about Alkylation. 180181-05-9 belongs to class piperidines, and the molecular formula is C22H23NO4, Application In Synthesis of 180181-05-9.

Mothukuri, Ganesh K.; Kale, Sangram S.; Stenbratt, Carl L.; Zorzi, Alessandro; Vesin, Jonathan; Bortoli Chapalay, Julien; Deyle, Kaycie; Turcatti, Gerardo; Cendron, Laura; Angelini, Alessandro; Heinis, Christian published the artcile< Macrocycle synthesis strategy based on step-wise ""adding and reacting"" three components enables screening of large combinatorial libraries>, Application In Synthesis of 180181-05-9, the main research area is plasma thrombin prothrombin thromboplastin X.

Macrocycles provide an attractive modality for drug development, but generating ligands for new targets is hampered by the limited availability of large macrocycle libraries. We have established a solution-phase macrocycle synthesis strategy in which three building blocks are coupled sequentially in efficient alkylation reactions that eliminate the need for product purification We demonstrate the power of the approach by combinatorially reacting 15 bromoacetamide-activated tripeptides, 42 amines, and 6 bis-electrophile cyclization linkers to generate a 3780-compound library with minimal effort. Screening against thrombin yielded a potent and selective inhibitor (Ki = 4.2 ± 0.8 nM) that efficiently blocked blood coagulation in human plasma. Structure-activity relationship and X-ray crystallog. anal. revealed that two of the three building blocks acted synergistically and underscored the importance of combinatorial screening in macrocycle development. The three-component library synthesis approach is general and offers a promising avenue to generate macrocycle ligands to other targets.

Chemical Science published new progress about Alkylation. 180181-05-9 belongs to class piperidines, and the molecular formula is C22H23NO4, Application In Synthesis of 180181-05-9.

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

 

Mazur, Robert H’s team published research in Journal of Organic Chemistry in 1961 | 25504-47-6

Journal of Organic Chemistry published new progress about Analgesics. 25504-47-6 belongs to class piperidines, and the molecular formula is C7H11NO3, SDS of cas: 25504-47-6.

Mazur, Robert H. published the artcile< Resolution and configuration of 1-(3-hydroxy-3-phenylpropyl)-4-ethoxycarbonyl-4-phenylpiperidine>, SDS of cas: 25504-47-6, the main research area is .

The title carbinol, Ph(EtO2C)C5H8NCH2CH2CH(OR)Ph (I, R = H) (II), was prepared for pharmacol. evalution since it should exhibit greater stability than the corresponding ketone (III), a Mannich base with analgesic properties, and its resolution could lead to a separation of analgesic and respiratory depressant activities. III HCl salt (12.0 g.) in 48 ml. 50% alc. and 1.2 g. NaOH in 72 ml. alc. stirred 10 min. at 20° with 1.1 g. NaBH4, diluted with CHCl3, the washed and dried CHCl3 extract distilled, and the crystalline residue, m. 89-91°, in 60 ml. Me2CHOH treated with 6.6 ml. 6.8N HCl in Me2CHOH gave 96% material, recrystallized from Me2CHOH to give dl-II HCl salt, m. 198-9°. II (3.7 g.) in 40 ml. C5H5N and 10 ml. Ac2O heated on a steam bath briefly and kept 16 hrs. at 20°, excess Ac2O decomposed with H2O, the solution taken up in Et2O, and the product on evaporation treated with 1.3 g. maleic acid in Et2O gave 94% product, recrystallized to give I (R = Ac) H maleate salt (IV), m. 137-9°. Similarly, 3.7 g. II and 3.9 g. (EtCO)2O yielded I (R = EtCO) H maleate salt (V), m. 142-3°. II (3.7 g.) in 20 ml. C5H5N kept 3 hrs. with 3.5 ml. l-menthoxyacetyl chloride with occasional swirling, the clear cold solution (ice bath) treated with 2 ml. H2O and diluted with Et2O, the product from evaporation of the washed and dried Et2O extract taken up in 15 ml. EtOAc and heated with 1.4 g. maleic acid, the filtered solution concentrated, and the residue treated with 50 ml. dry Et 2O yielded 93% salt, m. 79-86°, [α]D -30°, crystallized (50 g.) from 150 ml. alc. and 2.5 ml. to give 9.2 g. material, m. 137-9°, recrystallized from 18 ml. alc. and 450 ml. Et2O to yield 33% I (R = menthoxyacetyl) l,l-hydrogen maleate (VI), m. 139-40°, [α]D -50° (1% MeOH). The optically pure VI (6.8 g.) in 70 ml. MeOH hydrolyzed with 2.8 g. KOH in 35 ml. 80% MeOH 15 min. at 20° and the solution diluted with 200 ml. H2O gave the free base (3.7 g., m. 83-4°), recrystallized from dilute MeOH to yield l-II, m. 86.0-6.5°, [α]D -21°, acidified (1.1 g.) in 5 ml. Me2CHOH with 1 ml. 6.8N HCl in Me2CHOH to give 0.9 g. salt, m. 187-8°, crystallized from 5 ml. Me2CHOH to yield 67% l-II HCl salt, m. 187-8°, [α]D -23°. l-II (1.1 g.) kept 16 hrs. at 20° in 10 ml. C5H5N and 5 ml. Ac2O, excess Ac2O decomposed with 5 ml. H2O, taken up in Et2O and the washed and dried Et2O layer added to 0.4 g. maleic acid in 0.8 ml. MeOH and 10 ml. Et2O, filtered from 1.5 g. product, m. 141-2°, and crystallized from 5 ml. alc. and 75 ml. Et2O yielded 87% l-IV, m. 142-3°, [α]D -22°. Similarly, use of (EtCO)2O gave 80% l-V, m. 143-4°, [α]D -23°. Acylation of 35.0 g. II with 22.1 g. d-menthoxyacetyl chloride yielded, after fractional crystallization, 49% optically pure I (R = menthoxyacetyl) d,d-hydrogen maleate (VII), m. 138.0-8.5°, [α]D 50°, hydrolyzed (13.6 g.) to give 5.2 g. d-II HCl salt, m. 186-7°, [α]D 25°. l-II (1.9 g.) acetylated, the oily ester taken up in 100 ml. dry C6H6 and refluxed 5 hrs. with BrCN, C6H6 removed, the residue refluxed 5 hrs. with 0.8 g. LiAlH4 in 100 ml. dry tetrahydrofuran, excess LiAlH4 destroyed with EtOAc, the mixture treated with dilute HCl and Et2O, the residue on evaporation of the Et2O layer heated 2 hrs. on a steam bath with 1.0 ml. α-C10H7NCO, excess reagent destroyed with 90% aqueous Me2CO, the residue on evaporation taken up in ligroine (b. 60-80°) and chromatographed over 20 g. silica gel, the column washed with 500 ml. 1:1 C6H6-ligroine and eluted with C6H6, and the fraction crystallized from ligroine gave 0.8 g. needles, m. 113-15°, recrystallized from ligroine to give l-α-C10H7NHCO2CHPhEt, m. 116-17°, [α]D -31.5°, also produced by conversion of l-HOCHPhEt (VII) to the urethan. A duplicate experiment using 3.7 g. racemic base gave dl-α-C10H7NHCO2CHPhEt, m. 102-3° (ligroine). VII had the S configuration and l-II was S-1-(3-hydroxy-3-phenylpropyl)-4-ethoxycarbonyl-4-phenylpiperidine. The analgesic potencies in mice are listed (morphine = 1): dl-II HCl, 14; dl-IV, 8; dl-V 14; l-II HCl, 25; l-IV, 11; l-V, 14; d-II, HCl, 7. An increase in analgesic activity was accompanied by an approximately corresponding increase in respiratory depression.

Journal of Organic Chemistry published new progress about Analgesics. 25504-47-6 belongs to class piperidines, and the molecular formula is C7H11NO3, SDS of cas: 25504-47-6.

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

 

Leighty, Matthew W’s team published research in ACS Medicinal Chemistry Letters in 2011-04-30 | 149518-50-3

ACS Medicinal Chemistry Letters published new progress about Antitumor agents. 149518-50-3 belongs to class piperidines, and the molecular formula is C12H21NO4, Related Products of 149518-50-3.

Leighty, Matthew W.; Georg, Gunda I. published the artcile< Total Syntheses and Cytotoxicity of (R)- and (S)-Boehmeriasin A>, Related Products of 149518-50-3, the main research area is boehmeriasin A alkaloid enantioselective synthesis anticancer cytotoxicity.

Both enantiomers of boehmeriasin A were synthesized in seven steps each using a chiral pool approach. Key steps in the syntheses were a one-flask, two-step protocol to generate the quinolizine core and a C-H functionalization reaction between tetrahydroquinolizinones and an aryltrifluoroborate. The natural product (R)-boehmeriasin A (I) demonstrated potent cytotoxicity against several cancer cell lines, whereas the unnatural (+)-(S)-isomer was significantly less potent.

ACS Medicinal Chemistry Letters published new progress about Antitumor agents. 149518-50-3 belongs to class piperidines, and the molecular formula is C12H21NO4, Related Products of 149518-50-3.

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

 

Peschke, Bernd’s team published research in European Journal of Medicinal Chemistry in 1999-05-31 | 149518-50-3

European Journal of Medicinal Chemistry published new progress about Peptidomimetics. 149518-50-3 belongs to class piperidines, and the molecular formula is C12H21NO4, HPLC of Formula: 149518-50-3.

Peschke, Bernd; Ankersen, Michael; Hansen, Birgit Sehested; Hansen, Thomas Kruse; Johansen, Nils Langeland; Lau, Jesper; Madsen, Kjeld; Petersen, Hans; Thogersen, Henning; Watson, Brett published the artcile< Synthesis and in vitro characterization of new growth hormone secretagogues derived from ipamorelin with dipeptidomimetic N-terminals>, HPLC of Formula: 149518-50-3, the main research area is ipamorelin N terminal dipeptidomimetic derivative preparation; peptidomimetic derivative N terminal ipamorelin growth hormone secretagogue property; structure effect growth hormone secretagogue property peptidomimetic ipamorelin.

The structural requirements for N-terminal features for the minimal structure of growth hormone secretagogues derived from ipamorelin are investigated. It is found, that incorporation of nonpolar peptidomimetic amino acids at the N-terminal can replace the Aib-His moiety and lead to compounds with high in vitro potency with respect to their growth hormone secretagogue properties. New unnatural amino acids with double bonds, ether-linkages, and 1,3-phenylene-moieties in the backbone proved to be valuable dipeptidomimetics. Using them, growth hormone secretagogues with high potencies were obtained.

European Journal of Medicinal Chemistry published new progress about Peptidomimetics. 149518-50-3 belongs to class piperidines, and the molecular formula is C12H21NO4, HPLC of Formula: 149518-50-3.

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

 

Tang, Haifeng’s team published research in Bioorganic & Medicinal Chemistry Letters in 2010 | CAS: 766508-67-2

3-(Piperidin-4-yl)benzoic acid(cas: 766508-67-2) belongs to piperidines. Piperidine derivatives are also used in solid-phase peptide synthesis (SPPS) and many degradation reactions. Application In Synthesis of 3-(Piperidin-4-yl)benzoic acid

Application In Synthesis of 3-(Piperidin-4-yl)benzoic acidOn October 15, 2010 ,《Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities》 was published in Bioorganic & Medicinal Chemistry Letters. The article was written by Tang, Haifeng; Yan, Yan; Feng, Zhe; de Jesus, Reynalda K.; Yang, Lihu; Levorse, Dorothy A.; Owens, Karen A.; Akiyama, Taro E.; Bergeron, Raynald; Castriota, Gino A.; Doebber, Thomas W.; Ellsworth, Kenneth P.; Lassman, Michael E.; Li, Cai; Wu, Margaret S.; Zhang, Bei B.; Chapman, Kevin T.; Mills, Sander G.; Berger, Joel P.; Pasternak, Alexander. The article contains the following contents:

A new series of thiazole-substituted 1,1,1,3,3,3-hexafluoro-2-propanols, e.g. I, were prepared and evaluated as malonyl-CoA decarboxylase (MCD) inhibitors. Key analogs caused dose-dependent decreases in food intake and body weight in obese mice. Acute treatment with these compounds also led to a drop in elevated blood glucose in a murine model of type II diabetes. The results came from multiple reactions, including the reaction of 3-(Piperidin-4-yl)benzoic acid(cas: 766508-67-2Application In Synthesis of 3-(Piperidin-4-yl)benzoic acid)

3-(Piperidin-4-yl)benzoic acid(cas: 766508-67-2) belongs to piperidines. Piperidine derivatives are also used in solid-phase peptide synthesis (SPPS) and many degradation reactions. Application In Synthesis of 3-(Piperidin-4-yl)benzoic acid

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

 

Zhou, Mingsong’s team published research in Journal of Agricultural and Food Chemistry in 2019 | CAS: 826-36-8

Triacetonamine(cas: 826-36-8) is a member of piperidine. Piperidine is ubiquitous structural motif widely occurred in diverse synthetically and naturally occurring bioactive molecules. Piperidines are an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.Application In Synthesis of Triacetonamine

Application In Synthesis of TriacetonamineOn October 9, 2019 ,《Synthesis of a Hindered Amine-Grafted Lignin-Based Emulsifier and Its Application in a Green Emulsifiable Concentrate》 was published in Journal of Agricultural and Food Chemistry. The article was written by Zhou, Mingsong; Wang, Dongping; Peng, Ruifen; Yang, Dongjie; Qiu, Xueqing; Qian, Yong. The article contains the following contents:

The 4-amion-2,2,6,6-tetramethylpiperidine (Temp) was grafted into the Sodium Lignosulfonate (SL) to obtain the hindered amine modified lignosulfonate (SL-Temp). Then the polymer surfactant (SL-Temp-CTAB) was prepared by using cetyltrimethylammonium bromide (CTAB) and SL-Temperature The obtained SL-Temp-CTAB was used as emulsifier to prepare green Emulsifiable Concentrate (EC) of avermectin (AVM), which shows good emulsifying property and storage stability. The prepared AVM green EC can form AVM-loaded microspheres with nanometer particle size distribution after emulsification in water. After UV irradiation for 70 h, the AVM retention rate of the green EC prepared using SL-Temp-CTAB was 75.8%, which is much higher than that of com. EC (0.4%) and the green EC prepared using unmodified SL (31.4%). Moreover, the AVM green EC prepared using SL-Temp-CTAB has slow-release performance, and the release equilibrium time is 5.3 times of the com. EC. Therefore, the newly prepared AVM green EC using lignin-based functional emulsifier shows good anti-photolysis and slow-release performance compared with the traditional EC. In the experimental materials used by the author, we found Triacetonamine(cas: 826-36-8Application In Synthesis of Triacetonamine)

Triacetonamine(cas: 826-36-8) is a member of piperidine. Piperidine is ubiquitous structural motif widely occurred in diverse synthetically and naturally occurring bioactive molecules. Piperidines are an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.Application In Synthesis of Triacetonamine

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

 

Shoji, Atsushi’s team published research in Journal of the American Chemical Society in 2007 | CAS: 24666-55-5

Benzyl (2,6-dioxopiperidin-3-yl)carbamate(cas: 24666-55-5) belongs to anime. Acylation is one of the most important reactions of primary and secondary amines; a hydrogen atom is replaced by an acyl group (a group derived from an acid, such as RCOOH or RSO3H, by removal of ―OH, such as RC(=O)―, RS(O)2―, and so on). Reagents may be acid chlorides (RCOC1, RSO2C1), anhydrides ((RCO)2O), or even esters (RCOOR′); the products are amides of the corresponding acids.Recommanded Product: Benzyl (2,6-dioxopiperidin-3-yl)carbamate

Shoji, Atsushi; Kuwahara, Masayasu; Ozaki, Hiroaki; Sawai, Hiroaki published an article on February 7 ,2007. The article was titled 《Modified DNA Aptamer That Binds the (R)-Isomer of a Thalidomide Derivative with High Enantioselectivity》, and you may find the article in Journal of the American Chemical Society.Recommanded Product: Benzyl (2,6-dioxopiperidin-3-yl)carbamate The information in the text is summarized as follows:

A thalidomide-binding aptamer was produced by systematic evolution of ligands by exponential enrichment from a library of non-natural DNA in which thymidine had been replaced with a modified deoxyuridine bearing a cationic functional group via a hydrophobic methylene linker at the C5 position. The addnl. functional group in the modified DNA aptamer could improve stability against nucleases and increase the binding affinity to thalidomide. The selected aptamer could recognize thalidomide enantioselectively, although a racemic thalidomide-attached gel was used for the selection. Surface plasmon resonance and fluorescence titration studies revealed that the selected modified DNA aptamer and a truncated version bound with an (R)-thalidomide derivative with high enantioselectivity, but not with the (S)-form. The modified group in the DNA aptamer is indispensable for the interaction with thalidomide, as the corresponding natural type DNA bearing the same base sequence showed no binding affinity with (R)- nor (S)-thalidomide. Computational sequence anal. suggested that the selected apatamer (108mer) could fold into a three-way junction structure; however, truncation of this aptamer (31mer) revealed that the thalidomide-binding site is a hairpin-bulge region that is a component of one of the arms of the three-way junction structure. The Kd value of the truncated 31mer aptamer for binding with the (R)-thalidomide derivative was 1.0 μM estimated from fluorescence titration study. The aptamer that can recognize a single enantiomer of thalidomide will be useful as a biochem. tool for the anal. and study of the biol. action of thalidomide enantiomers. The results came from multiple reactions, including the reaction of Benzyl (2,6-dioxopiperidin-3-yl)carbamate(cas: 24666-55-5Recommanded Product: Benzyl (2,6-dioxopiperidin-3-yl)carbamate)

Benzyl (2,6-dioxopiperidin-3-yl)carbamate(cas: 24666-55-5) belongs to anime. Acylation is one of the most important reactions of primary and secondary amines; a hydrogen atom is replaced by an acyl group (a group derived from an acid, such as RCOOH or RSO3H, by removal of ―OH, such as RC(=O)―, RS(O)2―, and so on). Reagents may be acid chlorides (RCOC1, RSO2C1), anhydrides ((RCO)2O), or even esters (RCOOR′); the products are amides of the corresponding acids.Recommanded Product: Benzyl (2,6-dioxopiperidin-3-yl)carbamate

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

 

Iwasaki, Takanori’s team published research in Journal of the American Chemical Society in 2013 | CAS: 622-26-4

2-(Piperidin-4-yl)ethanol(cas: 622-26-4) can be used to synthese ursolic acid derivatives, spiroimidazolidinone NPC1L1 inhibitors, neurokinin-2 receptor antagonists, antagonists for inhibition of platelet aggregation.Computed Properties of C7H15NO

In 2013,Iwasaki, Takanori; Takagawa, Hiroaki; Singh, Surya P.; Kuniyasu, Hitoshi; Kambe, Nobuaki published 《Co-Catalyzed Cross-Coupling of Alkyl Halides with Tertiary Alkyl Grignard Reagents Using a 1,3-Butadiene Additive》.Journal of the American Chemical Society published the findings.Computed Properties of C7H15NO The information in the text is summarized as follows:

In the presence of cobalt(II) chloride, lithium iodide, and either 1,3-butadiene or isoprene, alkyl Grignard reagents with β-hydrogen atoms such as tert-butylmagnesium chloride underwent coupling reactions with alkyl tosylates, fluorides, bromides, and iodides such as 1-bromooctane in THF at 50° to give alkanes such as 2,2-dimethyldecane in 55-91% isolated yields or in 58-95% GC yields; sterically congested quaternary carbon centers could be constructed by using tertiary alkyl Grignard reagents. Ester-, amide-, and tetrahydropyran-containing alkyl bromides were compatible with the reaction conditions. Coupling reactions of 6-bromo-1-hexene and cyclopropylmethyl bromide did not yield cyclized product and gave low yields (<4%) of ring-opened products, resp., while reaction in the presence of 9,10-dihydroanthracene gave product in low yield but with complete recovery of dihydroanthracene, implying that the coupling does not occur through radical intermediates. An ionic mechanism with inversion of stereochem. at the reacting site of the alkyl halide is proposed for the coupling reaction based on the stereoselectivity of reaction of a racemic dideuterated phenethyl bromide. The experimental part of the paper was very detailed, including the reaction process of 2-(Piperidin-4-yl)ethanol(cas: 622-26-4Computed Properties of C7H15NO)

2-(Piperidin-4-yl)ethanol(cas: 622-26-4) can be used to synthese ursolic acid derivatives, spiroimidazolidinone NPC1L1 inhibitors, neurokinin-2 receptor antagonists, antagonists for inhibition of platelet aggregation.Computed Properties of C7H15NO

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

 

Iwasaki, Takanori’s team published research in Angewandte Chemie, International Edition in 2015 | CAS: 622-26-4

2-(Piperidin-4-yl)ethanol(cas: 622-26-4) can be used to synthese ursolic acid derivatives, spiroimidazolidinone NPC1L1 inhibitors, neurokinin-2 receptor antagonists, antagonists for inhibition of platelet aggregation.Synthetic Route of C7H15NO

In 2015,Iwasaki, Takanori; Shimizu, Ryohei; Imanishi, Reiko; Kuniyasu, Hitoshi; Kambe, Nobuaki published 《Copper-catalyzed regioselective hydroalkylation of 1,3-dienes with alkyl fluorides and Grignard reagents》.Angewandte Chemie, International Edition published the findings.Synthetic Route of C7H15NO The information in the text is summarized as follows:

Copper complexes generated in situ from CuCl2, alkyl Grignard reagents, and 1,3-dienes play important roles as catalytic active species for the 1,2-hydroalkylation of 1,3-dienes by alkyl fluorides through C-F bond cleavage. The alkyl group is introduced to an internal carbon atom of the 1,3-diene regioselectively, thus giving rise to the branched terminal alkene product.2-(Piperidin-4-yl)ethanol(cas: 622-26-4Synthetic Route of C7H15NO) was used in this study.

2-(Piperidin-4-yl)ethanol(cas: 622-26-4) can be used to synthese ursolic acid derivatives, spiroimidazolidinone NPC1L1 inhibitors, neurokinin-2 receptor antagonists, antagonists for inhibition of platelet aggregation.Synthetic Route of C7H15NO

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem